Bridgeway Capital Management’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Hold
84,600
﹤0.01% 1126
2026
Q1
$129K Buy
84,600
+16,300
+24% +$21.4K ﹤0.01% 1097
2025
Q4
$84.7K Sell
68,300
-2,000
-3% -$2.8K ﹤0.01% 1145
2025
Q3
$142K Hold
70,300
﹤0.01% 1064
2025
Q2
$127K Buy
70,300
+35,000
+99% +$67.4K ﹤0.01% 1037
2025
Q1
$75.2K Buy
35,300
+2,000
+6% +$6.81K ﹤0.01% 1086
2024
Q4
$129K Sell
33,300
-25,000
-43% -$199K ﹤0.01% 1079
2024
Q3
$589K Buy
+58,300
New +$379K 0.01% 823

Other funds holding BMEA

Bridgeway Capital Management's BMEA Position: Q2 2026 in Review

Bridgeway Capital Management held its Biomea Fusion (BMEA) position steady in Q2 2026 at 84,600 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Bridgeway Capital Management first reported a position in BMEA in Q3 2024 and has held it in 8 quarters since. The position peaked at $589K in Q3 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Bridgeway Capital Management held 84,600 shares of Biomea Fusion worth $124K as of Q2 2026.
  • Bridgeway Capital Management left its Biomea Fusion share count unchanged in Q2 2026.
  • Biomea Fusion made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1126 holding.
  • Bridgeway Capital Management first reported a position in Biomea Fusion in Q3 2024 and has held it in 8 quarters since.
  • Bridgeway Capital Management's Biomea Fusion position peaked at $589K in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.